Evidence map›Paper›PMID 25734169›Full record

ArticleOpen forum infectious diseases2014

Mumps serum antibody levels before and after an outbreak to assess infection and immunity in vaccinated students.

Sigrid Gouma, Tessa M Schurink-Van't Klooster, Hester E de Melker, Jeroen Kerkhof, Gaby P Smits, Susan J M Hahné, Cécile A C M van Els, Greet J Boland, Ann C T M Vossen, Pulak R Goswami and 2 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Baseline antibody level may help predict the risk of active human cytomegalovirus infection in a HCMV seropositive population.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2017
    Article
  8. Article
  9. Mumps virus pathogenesis: Insights and knowledge gaps.Human vaccines & immunotherapeutics · 2016
    Article
  10. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Sigrid GoumaCentre for Infectious Disease Control , National Institute for Public Health and the Environment , Bilthoven , The Netherlands ; Department of Viroscience , Erasmus University Medical Centre , Rotterdam , The Netherlands.
Tessa M Schurink-Van't KloosterCentre for Infectious Disease Control , National Institute for Public Health and the Environment , Bilthoven , The Netherlands.
Hester E de MelkerCentre for Infectious Disease Control , National Institute for Public Health and the Environment , Bilthoven , The Netherlands.
Jeroen KerkhofCentre for Infectious Disease Control , National Institute for Public Health and the Environment , Bilthoven , The Netherlands.
Gaby P SmitsCentre for Infectious Disease Control , National Institute for Public Health and the Environment , Bilthoven , The Netherlands.
Susan J M HahnéCentre for Infectious Disease Control , National Institute for Public Health and the Environment , Bilthoven , The Netherlands.
Cécile A C M van ElsCentre for Infectious Disease Control , National Institute for Public Health and the Environment , Bilthoven , The Netherlands.
Greet J BolandDepartment of Medical Microbiology , University Medical Centre Utrecht , The Netherlands.
Ann C T M VossenDepartment of Medical Microbiology , Leiden University Medical Centre , The Netherlands.
Pulak R GoswamiDepartment of Medical Microbiology and Infection Prevention , Groene Hart Hospital , Gouda , The Netherlands.
Marion P G KoopmansCentre for Infectious Disease Control , National Institute for Public Health and the Environment , Bilthoven , The Netherlands ; Department of Viroscience , Erasmus University Medical Centre , Rotterdam , The Netherlands.
Rob S van BinnendijkCentre for Infectious Disease Control , National Institute for Public Health and the Environment , Bilthoven , The Netherlands.
National Institute for Public Health and the Environment · NLErasmus University Rotterdam · NLGroene Hart Ziekenhuis · NLLeiden University Medical Center · NLUniversity Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSince 2009, various mumps outbreaks have occurred in the Netherlands, affecting mostly young adults vaccinated against mumps. In this retrospective study, we estimated attack rates for symptomatic and asymptomatic mumps virus infection based on mumps-specific immunoglobulin (Ig)G concentrations in paired blood samples obtained before and after the mumps outbreaks, collected in 2 university cities. We aimed to identify a serological correlate of immune protection and risk factors for mumps virus infection.

methodsMumps-specific IgG levels were measured by Luminex technology in paired pre- and post-outbreak samples from students from Leiden (n = 135) and Utrecht (n = 619). Persons with a 4-fold increase in mumps IgG concentrations or mumps IgG concentrations >1500 RU/mL were assumed to have had a mumps virus infection.

resultsAttack rates for symptomatic and asymptomatic mumps virus infection were 2.0% and 3.8%, respectively. Pre-outbreak mumps-specific IgG concentrations were lower among cases than among noncases (P = .005) despite vaccination history, but no serological cutoff for immune protection could be established. Mumps among housemates was significantly associated with serological evidence for mumps virus infection (odds ratio, 7.25 [95% confidence interval, 3.20-16.40]; P < .001).

conclusionsSymptomatic and asymptomatic mumps virus infections in vaccinated persons can be identified by retrospective assessment of mumps-specific IgG antibodies in blood samples.

Indexed as

asymptomatic infectionattack ratescorrelate of protectionIgG antibodiesMMR vaccinationmumps virusrisk factorsserology

Identifiers

PMID25734169
PMCPMC4324217
OpenAlexW2141587946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.